Cargando…
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
INTRODUCTION: To evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT). PATIENTS AND METHODS: A total of 215 patients with locally advanced pancreatic cancer were treated with chemoradiation at a sing...
Autores principales: | Habermehl, Daniel, Kessel, Kerstin, Welzel, Thomas, Hof, Holger, Abdollahi, Amir, Bergmann, Frank, Rieken, Stefan, Weitz, Jürgen, Werner, Jens, Schirmacher, Peter, Büchler, Markus W, Debus, Jürgen, Combs, Stephanie E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338091/ https://www.ncbi.nlm.nih.gov/pubmed/22385572 http://dx.doi.org/10.1186/1748-717X-7-28 |
Ejemplares similares
-
Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection
por: Habermehl, Daniel, et al.
Publicado: (2013) -
Adjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma
por: Habermehl, Daniel, et al.
Publicado: (2015) -
Single-dose radiosurgical treatment for hepatic metastases - therapeutic outcome of 138 treated lesions from a single institution
por: Habermehl, Daniel, et al.
Publicado: (2013) -
Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas
por: Rieken, Stefan, et al.
Publicado: (2013) -
Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
por: Harrabi, Semi B, et al.
Publicado: (2014)